BMC Infectious Diseases

Table 2 Central and peripheral hemodynamic data during pulse wave analysis in patients with and without metabolic syndrome

From: Association of HIV-infection, antiretroviral treatment and metabolic syndrome with large artery stiffness: a cross-sectional study

	No Metabolic Syndrome			Metabolic Syndrome
Variable	Controls	HIV-1 untreated	HIV-1 cART	Controls	HIV-1 untreated	HIV-1 cART
Variable	(n = 39)	(n = 32)	(n = 42)	(n = 10)	(n = 16)	(n = 12)
Central systolic BP	113 ± 12	116 ± 10	114 ± 10	126 ± 7^c	120 ± 13	110 ± 11^b
Peripheral systolic BP	123 ± 13^a	127 ± 11^a	124 ± 11^a	135 ± 7^ac	129 ± 11^a	120 ± 13^a
Central diastolic BP	75 ± 7	78 ± 6	78 ± 8	81 ± 3^c	78 ± 6	74 ± 7^b
Peripheral diastolic BP	74 ± 7^a	77 ± 6^a	76 ± 8^a	79 ± 3^ac	72 ± 7^a	72 ± 7^ab
Central MAP	87 ± 8	91 ± 7	90 ± 9	96 ± 3^c	92 ± 7	86 ± 8^b
Peripheral MAP	90 ± 8^a	93 ± 7^a	92 ± 8^a	98 ± 2^ac	94 ± 7^a	87 ± 8^bc
Central PP	38 ± 9	38 ± 8	36 ± 7	45 ± 8^c	41 ± 9	36 ± 8
Peripheral PP	49 ± 10^a	50 ± 10^a	47 ± 7^a	56 ± 9^a	52 ± 9^a	45 ± 8^ab
PP amplification (ratio)	1.33 ± 0.17	1.33 ± 0.14	1.32 ± 0.13	1.24 ± 0.12	1.29 ± 0.12	1.25 ± 0.19
Heart rate (beats/min)	67 ± 11	76 ± 10^b	74 ± 11^b	66 ± 7	74 ± 6	78 ± 13^b

Values (mmHg) are means ± SD. cART combined antiretroviral therapy, BP blood pressure, MAP mean arterial pressure, PP pulse pressure, ^aP < 0.001 for within-group central variable, ^bP < 0.01 versus within-group controls, ^cP < 0.001 vs. no metabolic syndrome controls

Back to article page

ISSN: 1471-2334

Contact us

Submission enquiries: bmcinfectiousdiseases@biomedcentral.com
General enquiries: ORSupport@springernature.com